Humacyte
生物技术研究
Durham，NC 11,289 位关注者
Our vision is to be the global leader in engineering regenerative medicine products to save and improve patient lives.
Our Leadership Team
Our Goal: Treat the Untreatable
Humacyte is pioneering the development and manufacture of off-the-shelf, universally implantable bioengineered human tissues. The Acellular Tissue Engineered Vessel (ATEV) platform is a regenerative tissue currently in various stages of clinical trials targeting multiple applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease.
TechnologyInnovation at Commercial Scale
Humacyte, Inc. is developing a disruptive biotechnology platform to deliver universally implantable, bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. Humacyte currently develops and manufactures acellular tissues to address life and limb-threatening vascular conditions while focusing on potential future applications for complex tissue and organ diseases. Located in Durham, N.C., the company was founded in 2004.
Meet The TeamCulture & Benefits
- Stock Options - 401(k) Plan with Matching - Medical, Vision and Dental Plans - Long Term/Short Term Disability - Life Insurance - 23 Days Paid Time Off (PTO) - 11 Paid Holidays - Paid Parental Leave Policies - Career Development and Training
Career Opportunities